Christoph Martin

Christoph Martin is an experienced finance professional currently serving as CFO Germany and Managing Director for several subsidiaries at STADA Group since January 2021. Previously, Christoph held interim roles at Stadapharm GmbH and was Managing Director and CFO at BioNTech SE, overseeing significant financial operations and a major divestiture. With a strong background in finance and management from Novartis Manufacturing GmbH, where Christoph served as Managing Director and Head of Finance, and prior experience in executive consulting and strategy at firms such as Capgemini, Christoph has extensive expertise across finance, IT, and operational management. Christoph is pursuing the Stada Grow Higher Executive Program at IMD while holding a degree in Business Studies from the University of Mannheim.